In the present study we set out to expand these findings by exploring the status of IL-6 as a potent adipokine from visceral fat that induces hepatic IR and dyslipidemia, since it is known that it may affect iron metabolism as reported by others [4,7,8]. Here, IL6 is linked to hepatitis A virus infection.